Tango Therapeutics, Inc. (TNGX) Tango Therapeutics, Inc. is a clinical-stage biotechnology company developing targeted cancer therapies that exploit synthetic lethality—a novel approach to killing cancer cells while sparing healthy ones. With multiple programs in development, the company’s platform identifies genetic interactions that can guide precision oncology treatments. Tango is gaining momentum as interest in next-gen […]